chlorine has been researched along with oxidopamine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Garner, CD; Nachtman, JP | 1 |
| Bloom, FE; Deyo, SN; Magistretti, PJ; Shoemaker, WJ; Staunton, DA | 1 |
| Foley, DH | 1 |
| Atadzhanov, M | 1 |
| Bals-Kubik, R; Herz, A; Shippenberg, TS | 1 |
| Inglefield, JR; Kellogg, CK; Pleger, GL; Taylor, MK | 1 |
| Ehrenström, F; Söderpalm, A; Söderpalm, B | 1 |
| Church, WH; Fong, YT | 1 |
| Okada, S; Sawashita, J; Takeda, A; Takefuta, S | 1 |
| Burkhardt, K; Ludolph, AC; Schwarz, J; Storch, A | 1 |
| Blunt, SB; Datla, KP; Dexter, DT | 1 |
| Datla, KP; Dexter, DT; Gillies, GE; Murray, HE; Pillai, AV | 1 |
| Kabuto, H; Kohno, M; Tada, M | 1 |
| Iglesias-González, J; Labandeira-García, JL; Méndez-Alvarez, E; Muñoz-Patiño, A; Sánchez-Iglesias, S; Sánchez-Sellero, I; Soto-Otero, R | 1 |
| Aguilar, E; Marin, C; Mullol, J; Planas, AM; Soria, G; Tudela, R | 1 |
| Feng, XY; Li, LS; Liu, CZ; Xu, JD; Zhang, Y; Zheng, LF; Zhu, JX | 1 |
| Aarão, MC; Almeida, AG; Cecilio, SG; Finsterer, J; Medrado, JM; Moret, MA; Pires, AC; Rodrigues, AM; Santos, LEC; Scorza, CA; Scorza, FA; Viegas, MPC | 1 |
1 review(s) available for chlorine and oxidopamine
| Article | Year |
|---|---|
[Modeling parkinsonism (review)].
Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Animal; Globus Pallidus; Humans; Hydroxydopamines; Manganese; Manganese Compounds; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Rabbits; Rats; Red Nucleus; Reserpine; Substantia Nigra; Syndrome; Tetanus Toxin; Thalamus; Tungsten; Tungsten Compounds | 1982 |
16 other study(ies) available for chlorine and oxidopamine
| Article | Year |
|---|---|
Manganese catalyzed auto-oxidation of dopamine to 6-hydroxydopamine in vitro.
Topics: Chlorides; Chromatography, High Pressure Liquid; Dopamine; Hydroxydopamines; Kinetics; Manganese; Manganese Compounds; Oxidation-Reduction; Oxidopamine | 1989 |
Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Chlorides; Corpus Striatum; Dopamine; Haloperidol; Humans; Hydroxydopamines; Kinetics; Lithium; Lithium Chloride; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1982 |
Diminished arterial smooth muscle response to adenosine during Na-K pump inhibition.
Topics: Adenosine; Animals; Arteries; Chlorides; Hydroxydopamines; Ion Channels; Lithium; Lithium Chloride; Male; Muscle, Smooth, Vascular; Ouabain; Oxidopamine; Potassium; Rabbits; Sodium | 1984 |
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
Topics: Animals; Benzazepines; Chlorides; Conditioning, Classical; Dopamine; Dopamine D2 Receptor Antagonists; Lithium; Lithium Chloride; Male; Morphine; Motivation; Narcotics; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
Importance of hypothalamic function to stressor-induced responsiveness of the GABAA receptor in the cerebral cortex: a non-corticosterone influence.
Topics: Anesthetics; Animals; Behavior, Animal; Cerebral Cortex; Chlorides; Corticosterone; Desoxycorticosterone; Dopamine beta-Hydroxylase; Hypothalamus; Interpersonal Relations; Male; Norepinephrine; Oxidopamine; Paraventricular Hypothalamic Nucleus; Rats; Receptors, GABA-A; Stress, Psychological | 1993 |
The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Cerebral Cortex; Chlorides; Conflict, Psychological; Dihydroxyphenylalanine; Enzyme Inhibitors; gamma-Aminobutyric Acid; Hippocampus; Hydrazines; Hydroxyindoleacetic Acid; Male; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reserpine; Serotonin; Yohimbine | 1995 |
Changes in uric acid during acute infusion of MPP+, 6-OHDA, and FeCl3. A microdialysis study in the substantia nigra of the guinea pig.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Chlorides; Ferric Compounds; Guinea Pigs; Infusions, Intravenous; Male; Microdialysis; Oxidopamine; Substantia Nigra; Uric Acid | 1996 |
Distribution of zinc in the substantia nigra of rats treated with 6-hydroxydopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Autoradiography; Blood-Brain Barrier; Chlorides; Corpus Striatum; Gliosis; Homovanillic Acid; In Vitro Techniques; Injections, Intravenous; Male; Nerve Degeneration; Oxidopamine; Quaternary Ammonium Compounds; Radionuclide Imaging; Rats; Rats, Wistar; Substantia Nigra; Technetium Compounds; Time Factors; Zinc; Zinc Compounds; Zinc Radioisotopes | 1998 |
Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Animals; Cell Survival; Cells, Cultured; Chlorides; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Ferric Compounds; Humans; Levodopa; Lipid Peroxidation; Neuroglia; Neurons; Oxidative Stress; Oxidopamine; Rats; Riluzole | 2000 |
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Chlorides; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ferric Compounds; Immunoenzyme Techniques; Levodopa; Male; Neostriatum; Nerve Net; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |
Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorides; Diestrus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Estradiol; Estrogens; Estrous Cycle; Female; Ferric Compounds; Free Radicals; Homovanillic Acid; Injections; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Proestrus; Rats; Rats, Wistar; Substantia Nigra | 2003 |
Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.
Topics: Animals; Ascorbic Acid; Catalase; Chlorides; Corpus Striatum; Dopamine; Eugenol; Ferric Compounds; Free Radical Scavengers; Glutathione; Glutathione Peroxidase; Injections, Subcutaneous; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Oxidopamine; Superoxides; Thiobarbituric Acid Reactive Substances | 2007 |
Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.
Topics: Adrenergic Agents; Aluminum Chloride; Aluminum Compounds; Analysis of Variance; Animals; Behavior, Animal; Brain; Catalase; Chlorides; Dopamine; Glutathione Peroxidase; Lipid Metabolism; Male; Mitochondria; Monoamine Oxidase; Oxidative Stress; Oxidopamine; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tyrosine 3-Monooxygenase | 2009 |
In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-
Topics: Animals; Basal Ganglia; Behavior, Animal; Chlorides; Diffusion Tensor Imaging; Dopamine Plasma Membrane Transport Proteins; Magnetic Resonance Imaging; Male; Manganese Compounds; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2011 |
Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic beta-2 Receptor Antagonists; Animals; Antiparkinson Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Chloride Channels; Chlorides; Colon; Cyclic AMP; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Motility; Intestinal Mucosa; Ion Transport; Male; Nitriles; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Time Factors | 2015 |
The nonsynaptic plasticity in Parkinson's disease: Insights from an animal model.
Topics: Adenosine Triphosphatases; Animals; Chlorides; Disease Models, Animal; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Symporters | 2023 |